FDA Approves Unknown Drug — AMNEAL PHARMS

# FDA Approves Amneal Pharmaceuticals Generic Drug Application Amneal Pharmaceuticals received FDA approval for ANDA205081 on April 22, 2016, expanding its generic drug portfolio and positioning the company to capture additional market share in the competitive generic pharmaceutical sector. The approval strengthens Amneal's ability to compete in the generic market and diversify its revenue streams across therapeutic categories.